NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.
NOWDiagnostics has raised $22.5M in total funding. The most recent round was Series B. The last funding was announced in July 2024.
NOWDiagnostics's investors include DigitalDx Ventures, Kristian Andersen, Kompass Kapital Management, LabCorp Venture Fund.
NOWDiagnostics is headquartered in Springdale, United States.
NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.
NOWDiagnostics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NOWDiagnostics — Funding & Investors." VCBacked, July 9, 2024, https://www.vcbacked.co/company/nowdiagnostics. Accessed September 14, 2026.
VCBacked. (2024). NOWDiagnostics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/nowdiagnostics
{{cite web |title=NOWDiagnostics — Funding & Investors |url=https://www.vcbacked.co/company/nowdiagnostics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated